Opinion|Videos|February 11, 2025
Lower Urinary Tract Overview
Author(s)Tamara Kaplan, MD
Panelist discusses how the neuroanatomy of bladder function involves a sophisticated interplay between autonomic and somatic nervous systems. The bladder is controlled by parasympathetic nerves (S2-S4) for detrusor contraction, sympathetic nerves (T11-L2) for sphincter control, and somatic nerves for voluntary control via the pudendal nerve. This complex coordination enables both automatic storage and voluntary voiding through reciprocal innervation.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Can you explain the neuroanatomy of bladder function and why it’s particularly complex?
Advertisement
Related to this article
The FDA accepted uniQure's biologics license application for ifezuntirgene inilparvovec and granted it Priority Review, setting a target action date of May 1, 2027.
Jeffrey Cohen, MD, professor of neurology and staff physician at the Cleveland Clinic Mellen Center for Multiple Sclerosis, discusses interim BREAKFREE-2 findings for zola-cel, a CD19-directed CAR T cell therapy, in relapsing and progressive MS.
Here's some of what is coming soon to NeurologyLive® this week.
Interim phase 1b/2a data showed all patients treated with high- or low-dose BB-301 for oculopharyngeal muscular dystrophy met formal response criteria.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is the history of neurology!
Although ocular signs in LEMS are typically mild and appear late, recognizing them alongside proximal weakness and autonomic symptoms can speed diagnosis and earlier detection of an associated lung cancer.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 30, 2026.
Shaida Khan, DO, associate professor of neurology at UT Southwestern Medical Center, reflected on a recent NeurologyLive Clinical Forum on generalized myasthenia gravis and discussed how FcRn and complement inhibitors are reshaping treatment algorithms for the disease.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Understanding Cemdisiran's Mechanism of Action in Myasthenia Gravis
2
Zola-Cel and Treatment-Free Remission: What the BREAKFREE-2 Data Show
3
FDA Grants Priority Review to Huntington Disease Gene Therapy BLA
4
Benitec Reports Positive Interim Results for BB-301 in Oculopharyngeal Muscular Dsytrophy
5